Carcinoma In Situ (CIS) of the Urinary Bladder
- 24 July 2025
- book chapter
- Published by Springer Nature
- p. 151-161
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Validation of Confocal Laser Endomicroscopy Features of Bladder Cancer: The Next Step Towards Real-time Histologic GradingEuropean Urology Focus, 2020
- Clinical usefulness of random biopsies in diagnosis and treatment of non-muscle invasive bladder cancer: Systematic review and meta-analysisActas Urológicas Españolas, 2018
- Progression of urothelial carcinoma in situ of the urinary bladder: a switch from luminal to basal phenotype and related therapeutic implicationsVirchows Archiv, 2018
- Comprehensive Transcriptional Analysis of Early-Stage Urothelial CarcinomaCancer Cell, 2016
- Different subtypes of carcinoma in situ of the bladder do not have a different prognosisVirchows Archiv, 2013
- Photodynamic Diagnosis in Non–Muscle-Invasive Bladder Cancer: A Systematic Review and Cumulative Analysis of Prospective StudiesEuropean Urology, 2010
- Urinary Markers in Bladder CancerEuropean Urology, 2008
- HSP90 Expression: A New Predictive Factor for BCG Response in Stage Ta-T1 Grade 3 Bladder TumoursEuropean Urology, 2007
- Intravesical Instillations with Bacillus Calmette-Guérin for the Treatment of Carcinoma In Situ Involving Prostatic DuctsEuropean Urology, 2006
- Effect of intravesical bacillus calmette-guerin (BCG) on carcinomain situ of the bladderCancer, 1983